CannaPharmaRx Inc.

09/17/2024 | Press release | Distributed by Public on 09/17/2024 08:41

Management Change/Compensation Form 8 K

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Resignation of Chief Executive Officer

Pursuant to notice provided to the Company, Dean Medwid stepped down as the Chief Executive Officer ("CEO") of CannaPharmaRX, Inc. (the "Company") for personal reasons. There was no disagreement between Mr. Medwid and the Company on any matter related to the Company's operations, policies or practices that led to Mr. Medwid's resignation as CEO. The Company appreciates Mr. Medwid's dedication and service to the Company. The Company is looking to work with Mr. Medwid on a smooth transition and minimal interruption to our operations.

The Company's Board of Directors has started the process of finding a suitable replacement CEO for the Company. In the interim, the Board of Directors will work collectively with Company staff and employees to manage the day-to-day operations of the Company.